Well-known booming voice and familiar face enter Nuneaton and Bedworth history books coventrytelegraph.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from coventrytelegraph.net Daily Mail and Mail on Sunday newspapers.
CEO and President of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Murray Richard /Ca/, sells 11,816 shares worth $82,712
According to Jounce Therapeutics, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:21 AM, company CEO and President, Murray Richard /Ca/ disclosed selling 11,816 shares at a cost of $7.00. At the time of this transaction (Jan 08), this trade was worth $82,712 in total. As of Jan 08, Murray Richard /Ca/ now owns 140,371 shares in total worth about $1,026,112.0099999999.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) CEO and President, Murray Richard /Ca/, we have the following information:
CEO and President of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Murray Richard /Ca/, sells 10,183 shares worth $68,837
According to Jounce Therapeutics, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:21 AM, company CEO and President, Murray Richard /Ca/ disclosed selling 10,183 shares at a cost of $6.76. At the time of this transaction (Jan 07), this trade was worth $68,837 in total. As of Jan 07, Murray Richard /Ca/ now owns 152,187 shares in total worth about $1,112,486.97.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) CEO and President, Murray Richard /Ca/, we have the following information: